Reuters: Drug combination reduces colon cancer risk: study

[NaDiNe]

Drug combination reduces colon cancer risk: study
      

SAN DIEGO (Reuters) - Combining a low dose of targeted cancer-fighter DFMO with an anti-inflammatory drug reduces the risk of new colorectal polyps, an early sign of colon cancer, by as much as 95 percent, researchers said on Monday.
<p>You are not allowed to view links. Register or Login</p><div class="feedflare">
You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login You are not allowed to view links. Register or Login
</div><img src="You are not allowed to view links. Register or Login" height="1" width="1"/>
      

You are not allowed to view links. Register or Login